These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10701327)

  • 1. [Blood pressure variability and cardiovascular morbimortality].
    Robles NR
    Rev Esp Cardiol; 2000 Jan; 53(1):110-6. PubMed ID: 10701327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure variability in hypertension: a possible cardiovascular risk factor.
    Kario K
    Am J Hypertens; 2004 Nov; 17(11 Pt 1):1075-6. PubMed ID: 15533737
    [No Abstract]   [Full Text] [Related]  

  • 3. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why lowering blood pressure is not enough: the hypertension syndrome and the clinical context of cardiovascular risk reduction.
    Neutel JM
    Heart Dis; 2000; 2(5):370-4. PubMed ID: 11728284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular permeability, blood pressure, and organ damage in primary hypertension.
    Viazzi F; Leoncini G; Ratto E; Parodi A; Falqui V; Conti N; Tomolillo C; Ravera G; Deferrari G; Pontremoli R
    Hypertens Res; 2008 May; 31(5):873-9. PubMed ID: 18712042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies.
    Su DF
    Curr Opin Cardiol; 2006 Sep; 21(5):486-91. PubMed ID: 16900013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood pressure variability--clinical implications].
    Goch A
    Pol Merkur Lekarski; 2008 Oct; 25(148):364-7. PubMed ID: 19145938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure variability and cardiovascular risk in treated hypertensive patients.
    Pierdomenico SD; Lapenna D; Di Tommaso R; Di Carlo S; Esposito AL; Di Mascio R; Ballone E; Cuccurullo F; Mezzetti A
    Am J Hypertens; 2006 Oct; 19(10):991-7. PubMed ID: 17027816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes and consequences of a non-dipping blood pressure profile.
    Birkenhäger AM; van den Meiracker AH
    Neth J Med; 2007 Apr; 65(4):127-31. PubMed ID: 17452760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular hypertrophy: a potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure.
    Mansoor GA; Massie BM
    Blood Press Monit; 1999; 4 Suppl 1():S19-22. PubMed ID: 10822413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of elevated white blood cell count in hypertension.
    Schillaci G; Pirro M; Pucci G; Ronti T; Vaudo G; Mannarino MR; Porcellati C; Mannarino E
    Am J Hypertens; 2007 Apr; 20(4):364-9. PubMed ID: 17386341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
    Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
    Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morning rise, morning surge and daytime variability of blood pressure and cardiovascular target organ damage. A cross-sectional study in 743 subjects.
    Polónia J; Amado P; Barbosa L; Nazaré J; Silva JA; Bertoquini S; Martins L; Carmona J
    Rev Port Cardiol; 2005 Jan; 24(1):65-78. PubMed ID: 15773667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal participation in cardiovascular risk in essential hypertension.
    Ruilope LM; Segura J; Campo C; Rodicio JL
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):309-15. PubMed ID: 15030289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian variability of blood pressure in obese children.
    Török K; Pálfi A; Szelényi Z; Molnár D
    Nutr Metab Cardiovasc Dis; 2008 Jul; 18(6):429-35. PubMed ID: 18063354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary sodium: the dark horse amongst cardiovascular and renal risk factors.
    Mimran A; du Cailar G
    Nephrol Dial Transplant; 2008 Jul; 23(7):2138-41. PubMed ID: 18456679
    [No Abstract]   [Full Text] [Related]  

  • 19. [Predictors of cardiovascular mortality and morbidity in hypertension].
    Laurent S
    Curr Med Res Opin; 2005; 21 Suppl 5():S7-11. PubMed ID: 16197646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.
    de Simone G; Wachtell K; Palmieri V; Hille DA; Beevers G; Dahlöf B; de Faire U; Fyhrquist F; Ibsen H; Julius S; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Devereux RB
    Circulation; 2005 Apr; 111(15):1924-31. PubMed ID: 15837945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.